 |  |
| BISNIS-27 | ||
| 582.617 | ||
| -17.4810 | -0.0291% | |
| COMPOSITE | ||
| 7,174.241 | ||
| -111.5420 | -0.0153% | |
| DBX | ||
| 1,616.811 | ||
| -11.4990 | -0.0071% | |
| I-GRADE | ||
| 234.691 | ||
| -4.7300 | -0.0198% | |
| IDX30 | ||
| 475.741 | ||
| -12.2880 | -0.0252% | |
| IDX80 | ||
| 130.208 | ||
| -2.7330 | -0.0206% | |
| IDXBUMN20 | ||
| 418.032 | ||
| -6.3330 | -0.0149% | |
| AUDRP | ||
| 10,310.300 | ||
| -10.9000 | -0.1056% | |
| EURRP | ||
| 17,080.200 | ||
| -22.4000 | -0.1310% | |
| JPYRP | ||
| 104.190 | ||
| -0.0400 | -0.0384% | |
| RP | ||
| 15,771.000 | ||
| -13.0000 | -0.0824% | |
| SINRP | ||
| 11,733.600 | ||
| 11.4000 | 0.0973% | |
Vaksin Merah Putih selesai menjalani uji praklinis di Universitas Airlangga, dan kini siap untuk uji klinis oleh PT Biotis Pharmaceuticals Indonesia. Uji klinis diharapkan berlangsung lancar sehingga vaksin dapat diproduksi massal pada 2022.
